Genetic engineering techniques have been used to significantly improve mosquito larvicides based on the bacteria Bacillus thuringiensis (Bt) subsp. israelensis (Bti) and Bacillus sphaericus (Bs). These new larvicides hold excellent promise for providing better and more cost-effective control of nuisance mosquitoes and vectors of important diseases, including the anopheline vectors of malaria and culicine vectors responsible for filariasis and viral encephalitides. The toxicity of Bti and Bs is due primarily to endotoxin proteins produced during sporulation. After ingestion by larvae, these are activated and destroy the larval stomach, quickly resulting in death. By cloning the genes encoding various endotoxins from Bt and Bs species, and engineering these for high levels of synthesis, we have been able to generate recombinant bacterial strains based on Bti that are more than 10 times as effective as the conventional strains of Bti or Bs that serve as the active ingredients of commercial bacterial larvicides currently used for mosquito control. The best of these recombinants contain all major Bti endotoxins, specifically, Cry4A, Cry4B, Cry11A, and Cyt1A, plus the binary (Bin) endotoxin of Bs, the principal mosquitocidal protein responsible for the activity of this species. The presence of Cyt1A in these recombinants, which synergizes Cry toxicity and delays resistance to these proteins and Bs Bin, should enable long term use of these recombinants with little if any development of resistance. In the field, these new recombinants should be particularly effective larvicides against most important vectors and nuisance species of the genus Culex, the malaria vectors Anopheles gambiae and An. arabiensis, and species of Aedes and Ochlerotatus sensitive to Bs.

The ascovirus, DpAV4a (family Ascoviridae), is a symbiotic virus that markedly increases the fitness of its vector, the parasitic ichneumonid wasp, Diadromus puchellus, by increasing survival of wasp eggs and larvae in their lepidopteran host, Acrolepiopsis assectella. Previous phylogenetic studies have indicated that DpAV4a is related to the pathogenic ascoviruses, such as the Spodoptera frugiperda ascovirus 1a (SfAV1a) and the lepidopteran iridovirus (family Iridoviridae), Chilo iridescent virus (CIV), and is also likely related to the ancestral source of certain ichnoviruses (family Polydnaviridae). To clarify the evolutionary relationships of these large double-stranded DNA viruses, we sequenced the genome of DpAV4a and undertook phylogenetic analyses of the above viruses and others, including iridoviruses pathogenic to vertebrates. The DpAV4a genome consisted of 119,343 bp and contained at least 119 open reading frames (ORFs), the analysis of which confirmed the relatedness of this virus to iridoviruses and other ascoviruses. Analyses of core DpAV4a genes confirmed that ascoviruses and iridoviruses are evolutionary related. Nevertheless, our results suggested that the symbiotic DpAV4a had a separate origin in the iridoviruses from the pathogenic ascoviruses, and that these two types shared parallel evolutionary paths, which converged with respect to virion structure (icosahedral to bacilliform), genome configuration (linear to circular), and cytopathology (plasmalemma blebbing to virion-containing vesicles). Our analyses also revealed that DpAV4a shared more core genes with CIV than with other ascoviruses and iridoviruses, providing additional evidence that DpAV4a represents a separate lineage. Given the differences in the biology of the various iridoviruses and ascoviruses studied, these results provide an interesting model for how viruses of different families evolved from one another.